T/NK-lymphoproliferative Disease
1 clinical trials · Condition
◉ Watch T/NK-lymphoproliferative Disease
| Record | Firm | Date |
|---|---|---|
| Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) (NCT02287311) | Baylor College of Medicine | 2015-02-01 |
Track T/NK-lymphoproliferative Disease automatically
Every clearance here is in the API, with alerts when new ones post.